- Home
- CODX vs IBIO Comparison
CODX vs IBIO Comparison
Compare CODX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODX | IBIO |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 16.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CODX | IBIO |
|---|---|---|
| Price | $0.18 | $1.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $2.25 | ★ $4.00 |
| AVG Volume (30 Days) | 1.6M | ★ 13.4M |
| Earning Date | 11-13-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $507,892.00 | $500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.89 | $11.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 185.71 |
| 52 Week Low | $0.22 | $0.56 |
| 52 Week High | $1.55 | $6.89 |
Technical Indicators
Market Signals| Indicator | CODX | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 30.03 | 50.62 |
| Support Level | $0.22 | $1.78 |
| Resistance Level | $0.30 | $1.96 |
| Average True Range (ATR) | 0.03 | 0.37 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 2.05 | 0.24 |
Price Performance
Historical ComparisonAbout CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.